Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
0(0%)
Results Posted
100%(7 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_3
3
30%
Ph not_applicable
6
60%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution9 total trials
Phase 3Large-scale testing
3(33.3%)
N/ANon-phased studies
6(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(7)
Terminated(1)
Other(2)

Detailed Status

Completed7
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
87.5%
Most Advanced
Phase 3

Trials by Phase

Phase 33 (33.3%)
N/A6 (66.7%)

Trials by Status

terminated110%
completed770%
unknown220%

Recent Activity

0 active trials
Showing 5 of 10
completednot_applicable

MONOVISC for Ankle Joint Pain Relief Due to Osteoarthritis

NCT04204278
completednot_applicable

MONOVISC for Shoulder Joint Pain Relief Due to Osteoarthritis

NCT04204265
completednot_applicable

MONOVISC for Hip Joint Pain Relief Due to Osteoarthritis

NCT04204083
completednot_applicable

Comparative Study of Two Hyaluronic Acid Formulation in the Management of Knee Osteoarthritis

NCT06528600
completednot_applicable

Safety and Effectiveness of Monovisc® Injection for Osteoarthritis of the Knee

NCT00653432
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT04204278Not Applicable

MONOVISC for Ankle Joint Pain Relief Due to Osteoarthritis

Completed
NCT04204265Not Applicable

MONOVISC for Shoulder Joint Pain Relief Due to Osteoarthritis

Completed
NCT04204083Not Applicable

MONOVISC for Hip Joint Pain Relief Due to Osteoarthritis

Completed
NCT06528600Not Applicable

Comparative Study of Two Hyaluronic Acid Formulation in the Management of Knee Osteoarthritis

Completed
NCT00653432Not Applicable

Safety and Effectiveness of Monovisc® Injection for Osteoarthritis of the Knee

Completed
NCT03390036Phase 3

Study of Cingal for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide at 39 Weeks Follow up

Completed
NCT03191903Phase 3

Study of Cingal™ for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide

Completed
NCT02698865Phase 3

The MONOVISC Hip Osteoarthritis Study

Terminated
NCT01998308

Comparison Between Four Types of Single Dose Hyaluronic Acid Injection in Patients With Knee Osteoarthritis

Unknown
NCT02476903Not Applicable

Viscosupplementation in the Hip Following Hip Arthroscopy

Unknown

All 10 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
10